News & Updates
Filter by Specialty:
Which signs separate MIS-C from COVID-19, Kawasaki disease, toxic shock syndrome?
Children with multisystem inflammatory syndrome in children (MIS-C) show significantly higher prevalence of cardiac complications, elevated markers of inflammation and cardiac damage, thrombocytopenia, and lymphopenia than do those with COVID-19, Kawasaki disease (KD), and toxic shock syndrome (TSS), reports a study.
Which signs separate MIS-C from COVID-19, Kawasaki disease, toxic shock syndrome?
12 Apr 2022
CRP thresholds inform success of dexamethasone, tocilizumab against COVID-19 mortality
Using C-reactive protein (CRP) levels as indicators for early treatment with tocilizumab and dexamethasone can help reduce mortality in hospitalized patients with the coronavirus disease 2019 (COVID-19), a recent study has found.
CRP thresholds inform success of dexamethasone, tocilizumab against COVID-19 mortality
10 Apr 2022
Remdesivir raises pancreatic enzyme levels in 1 in 10 COVID-19 patients
Coronavirus disease 2019 (COVID-19) patients treated with remdesivir appear to be at a higher likelihood of having elevated pancreatic enzyme levels, a recent Japan study has found.
Remdesivir raises pancreatic enzyme levels in 1 in 10 COVID-19 patients
09 Apr 2022
SARS-CoV-2 tied to increased obstetric-related morbidity, mortality
SARS-CoV-2 infection during pregnancy or the postpartum period is tied to an increased risk of maternal mortality or serious morbidity due to obstetric complications, a study from the US showed.
SARS-CoV-2 tied to increased obstetric-related morbidity, mortality
08 Apr 2022
Anaphylaxis after COVID mRNA vaccination relatively rare
Anaphylactic reactions warranting treatment after receipt of COVID-19 mRNA vaccinations appear to be relatively rare, according to a US study presented at AAAAI 2022.
Anaphylaxis after COVID mRNA vaccination relatively rare
06 Apr 2022
Olfactory, gustatory disorders persist after COVID-19
Olfactory and gustatory dysfunctions, even when assessed through validated psychophysical tests, are common chronic symptoms after the coronavirus disease 2019 (COVID-19), a recent study has found.